BioLineRx (BLRX) Cash & Equivalents Growth (5y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.03% |
| Sep 30, 2025 | 8.36% |
| Jun 30, 2025 | 14.53% |
| Mar 31, 2025 | 12.24% |
| Dec 31, 2024 | 14.53% |
| Sep 30, 2024 | 12.58% |
| Jun 30, 2024 | -3.07% |
| Mar 31, 2024 | 6.44% |
| Dec 31, 2023 | 4.56% |
| Sep 30, 2023 | 10.44% |
| Jun 30, 2023 | 15.68% |
| Mar 31, 2023 | 3.03% |
| Dec 31, 2022 | 15.68% |
| Sep 30, 2022 | 14.12% |
| Jun 30, 2022 | 13.34% |
| Mar 31, 2022 | 39.06% |
| Dec 31, 2021 | 39.39% |
| Sep 30, 2021 | 33.20% |
| Jun 30, 2021 | 35.15% |
| Mar 31, 2021 | 28.48% |
| Dec 31, 2020 | 24.87% |
| Sep 30, 2020 | -0.09% |
| Jun 30, 2020 | -10.85% |
| Mar 31, 2020 | -8.88% |
| Dec 31, 2019 | -1.76% |
| Sep 30, 2019 | 0.76% |
| Jun 30, 2019 | -10.01% |
| Mar 31, 2019 | -13.71% |
| Dec 31, 2018 | -17.49% |
| Sep 30, 2018 | -17.28% |
| Jun 30, 2018 | -18.12% |
| Mar 31, 2018 | -9.39% |
| Dec 31, 2017 | -10.41% |